REPL::General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
07-Nov-2018 07:00:10
Status
Replacement
Announcement Sub Title
IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
Announcement Reference
SG181105OTHRAPND
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the presentation slides.
Attachments
iX Biopharma_BioEurope 2018 Presentation.pdf
Total size =1752K
Related Announcements
Related Announcements
05/11/2018 17:21:39